NCT01216956: Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia |
|
|
| Completed | N/A | 24 | Europe | Extended-release nicotinic acid versus placebo | Centre de Recherche en Nutrition Humaine Rhone-Alpe, Institut National de la Santé Et de la Recherche Médicale, France, GlaxoSmithKline | Insulin Sensitivity, Lipoproteins Metabolism, Non Esterified Fatty Acid Kinetics, Lipid Profile | 06/09 | 03/10 | | |